| Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612) |
|---|
| 02/22/2006 | CN1738797A Substituted aryl thioureas and related compounds; inhibitors of viral replication |
| 02/21/2006 | US7001918 7-pyrrolyl tetracycline compounds and methods of use thereof |
| 02/21/2006 | US7001901 Tetrazolylpropionamides as inhibitors of Aβ protein production |
| 02/21/2006 | CA2186224C Amidino derivatives useful as nitric oxide synthase inhibitors |
| 02/21/2006 | CA2184691C L-n6-(1-iminoethyl)lysine derivatives useful as nitric oxide synthase inhibitors |
| 02/15/2006 | CN1733743A N-cyclohexyl-5-(4-chlorobutyl)-1H-tetrazole synthesis method |
| 02/14/2006 | US6998423 Sulfonyl-amino or carbonyl-amino derivatives; osteoporosis bone disorders; therapeutic drug or kits including anti-resorptive agents, anabolic agents; |
| 02/14/2006 | CA2251850C Water-soluble tetrazolium salt compounds |
| 02/09/2006 | US20060030599 Sulphonamide derivatives |
| 02/09/2006 | CA2574971A1 Indanone potentiators of metabotropic glutamate receptors |
| 02/08/2006 | EP1622882A1 A METHOD OF PREPARATION OF N -(1-OXOPENTYL)- N-[[ 2-(1TETRAZOL-5-y1) [1,1 -BIPHENYL]-4-y1 METHYL] -L-VALINE (VALSARTAN) |
| 02/08/2006 | EP1622870A2 Glutaminyl based dp iv-inhibitors |
| 02/08/2006 | CN1730482A A temodar synthesis method |
| 02/02/2006 | US20060025474 Bisphenyl compounds useful as vitamin D3 receptor agonists |
| 02/01/2006 | EP1620091A2 Inhibitors of glutaminyl cyclase |
| 02/01/2006 | EP1476419B1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
| 02/01/2006 | CN1729158A Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 02/01/2006 | CN1727340A Temozolomide 8-carboxylic ester, and combination |
| 01/31/2006 | US6992184 Protecting the amino group of an amino acid, activating the carbonyl group of amino acid, reacting the carbonyl-activated amino acid with diamine to form a diamide diamine, deprotecting; reacting with activated di-carbonyl compound |
| 01/25/2006 | EP1618097A1 Process for the preparation of valsartan |
| 01/25/2006 | CN1238346C Method for producing 1-ethoxyl-5-mercapto-tetrazole |
| 01/24/2006 | US6989402 Thyroid receptor ligands and method II |
| 01/19/2006 | US20060014836 e.g. 1-(Benzofuran-2-carbonyl-3-(3-phenoxy-phenyl)-thiourea;viricides; hepatitis virus |
| 01/19/2006 | US20060013852 Use of organic compounds |
| 01/18/2006 | CN1723193A Novel polycyclic compounds which modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 01/17/2006 | CA2334713C Therapeutic biaryl derivatives |
| 01/12/2006 | WO2006002875A1 Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (mri) which contain a chelating moiety with polyhydroxylated substituents |
| 01/12/2006 | WO2006002874A1 Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (mri) which contain 1, 4, 7, 10-tertraazacyclodecan-1, 4, 7-triacetic acid chelating moiety with polyhydroxylated substituents |
| 01/12/2006 | WO2006002873A2 1 , 4 -bis (carboxymethyl) -6- ' bis ( carboxymethyl) amino ! -6 -methyl- perhydro-1 , 4 diazepine (aazta) derivatives as ligands in high relaxivity contrast agents for use in magnetic resonance imaging (mri ) |
| 01/12/2006 | US20060009484 Novel polycyclic compounds which modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 01/12/2006 | US20060008670 Organic light emitting materials and devices |
| 01/11/2006 | EP1614432A2 Method for treating amyloidosis |
| 01/11/2006 | EP1133291B1 Cyclic polyamines for treating thrombocytopenia |
| 01/11/2006 | CN1720043A Non-nucleoside reverse transcriptase inhibitors |
| 01/11/2006 | CN1718574A Chemical synthesis method of 1,2,3,4-tetra nitroazole kind compound |
| 01/11/2006 | CN1235886C Method for preparing 5-sulfhydyl-1-(m-benzamido) phenyl tetrazole |
| 01/05/2006 | US20060004021 Ethyl 4-{[2-(3-chlorophenyl)-2H-tetrazol-5-yl]methyl}piperazine-1-carboxylate; gastrointestinal disorders, chronic and acute pain, psychiatric and neurological disorders; obesity |
| 01/04/2006 | EP1611119A1 Pi-3 kinase inhibitor prodrugs |
| 01/04/2006 | EP1610812A1 Pharmaceutical preparations comprising acid-stabilised insulin |
| 01/04/2006 | CN1715278A Process for preparing candesartan cilexetil C-form crystal |
| 12/29/2005 | WO2005123700A1 Small molecules for treatment of hypercholesterolemia and related diseases |
| 12/29/2005 | WO2005062828A3 New compounds useful as metal chelators |
| 12/29/2005 | US20050288346 Acetophenone potentiators of metabotropic glutamate receptors |
| 12/29/2005 | US20050288345 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| 12/29/2005 | US20050288344 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| 12/29/2005 | US20050288320 Induce biosymthesis of cytokines, interferons, tumor necrosis factor; antitumor agents; viricides; chemical intermediates |
| 12/29/2005 | US20050288186 1-(4-{3-[2,6-Dichloro-4-(3,3-dichloro-allyloxy)-phenoxy]-propoxy}-phenyl)-1H-pyrrole, for example; protecting soybean plants against pests such as caterpillars |
| 12/29/2005 | CA2568539A1 Small molecules for treatment of hypercholesterolemia and related diseases |
| 12/28/2005 | EP1608374A1 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders |
| 12/28/2005 | EP1608352A1 Polyamine compounds for treating chemokine receptor mediated diseases |
| 12/28/2005 | CN1714076A Novel aryl ureido benzoic acid derivatives and their use |
| 12/28/2005 | CN1714070A Vitamin d receptor modulators |
| 12/28/2005 | CN1233633C Novel DIAR compound |
| 12/27/2005 | CA2189271C Novel erythromycin derivatives, method for their preparation and their use as drugs |
| 12/22/2005 | WO2005121109A2 Novel antiviral macrocycle derivatives and metal complexes, incorporating bridged macrocycles |
| 12/22/2005 | US20050282907 Benzothiazole or benzothiazine derivative of dipyrido(2,3;b:2',3'-e) diazepin-6-one; viricide against human t-cell leukemia/lymphoma virus |
| 12/22/2005 | US20050282899 Resorcinol derivatives |
| 12/22/2005 | US20050282872 Novel thyroid receptor ligands and method II |
| 12/22/2005 | DE102004026103A1 Trimere makrocyclisch substituierte Aminoisophthalsäure-Halogen-Benzolderivate Trimeric macrocyclic substituted aminoisophthalic-halo-benzene derivatives |
| 12/21/2005 | EP1606271A1 Insecticidal phthalamide derivatives |
| 12/21/2005 | CN1709877A 5-substituted aromatic laydrocarbon tetrazole production method |
| 12/15/2005 | WO2005118715A2 Gas generant and synthesis |
| 12/15/2005 | WO2005118575A1 Non nucleoside reverse transcriptase inhibitors |
| 12/15/2005 | WO2005087751A3 Substituted hydroxyethylamine aspartyl protease inhibitors |
| 12/15/2005 | WO2005075455A3 Methods for making 4-tetrazolyl-4-phenylpiperidine compounds |
| 12/15/2005 | WO2004078734A8 TETRAZOLE AND OXADIAZOLONE SUBSTITUTED β-AMINO ACID DERIVATIVES |
| 12/15/2005 | US20050277690 Small molecules for treatment of hypercholesterolemia and related diseases |
| 12/15/2005 | US20050276754 Bridged aromatic substituted amine ligands with donor atoms |
| 12/14/2005 | EP1603890A1 TETRAZOLE AND OXADIAZOLONE SUBSTITUTED &bgr;-AMINO ACID DERIVATIVES |
| 12/14/2005 | EP1603858A2 Kcnq channel modulating compounds and their pharmaceutical use |
| 12/08/2005 | WO2005116010A1 Ep4 receptor agonist, compositions and methods thereof |
| 12/08/2005 | WO2005115997A1 Trimeric macrocyclic substituted aminoisophthalate halophenyl derivatives |
| 12/08/2005 | WO2005097100A3 Antibacterial agents |
| 12/08/2005 | US20050272873 Gas generant and synthesis |
| 12/07/2005 | EP1602649A2 1,4,7,10-tetraazacyclododecane-1,4-diacetic acid derivatives as chelating agents |
| 12/07/2005 | EP1602642A1 Imino ether derivative compounds and drugs containing the compounds as the active ingredient |
| 12/07/2005 | CN1705648A Alpha-phenyl acetanilide derivatives having an ACAT inhibiting activity and the therapeutic application thereof |
| 12/06/2005 | US6972287 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits |
| 12/06/2005 | US6972281 Histogranin-like peptides and non-peptides, processes for their preparation and uses thereof |
| 12/01/2005 | WO2005113518A1 Process for preparing irbesartan |
| 12/01/2005 | WO2005113513A2 Aryl sulfonamides |
| 12/01/2005 | WO2005019167A3 Melanin concentrating hormone receptor antagonist |
| 12/01/2005 | WO2003027632A3 Use of isogenic human cancer cells for high-throughput screening and drug discovery |
| 12/01/2005 | US20050267183 Selective estrogen receptor modulators |
| 12/01/2005 | DE102004018746A1 Kohlenstoffmaterial Carbon material |
| 12/01/2005 | CA2566387A1 Aryl sulfonamides as chemokine receptor ccr9 antagonists |
| 11/30/2005 | EP1599174A2 Novel compounds |
| 11/30/2005 | EP1091943B1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 11/30/2005 | EP0888341B1 Novel sulphur derivatives comprising an amide bond, method for preparing same, use thereof as drugs, and pharmaceutical compositions containing such derivatives |
| 11/30/2005 | CN1229358C Novel tetrazolinone derivatives |
| 11/30/2005 | CN1229357C Lithium complexes of N-(1-hydroxymethyl-2,3-dihydroxypropyl)-1,4,7-triscarboxymethyl-l,4,7,10-tetraazacyclododecane, prodn. and use thereof |
| 11/29/2005 | US6969727 Obesity; osteoporosis |
| 11/29/2005 | US6969726 can be used as anti-proliferative agents and/or anti-infective agents that can be used without limitation as anti-inflammatory agents |
| 11/29/2005 | US6969697 Substituted benzoylcyclohexenones |
| 11/24/2005 | WO2005111003A1 Amino-tetrazoles analogues and methods of use |
| 11/24/2005 | US20050261293 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 11/24/2005 | US20050261291 1-Cyclopropylmethyl-4-[2-(3,3,5,5-tetramethylcyclohexyl)phenyl]piperazine or a salt or hydrate; exhibit excellent cell adhesion inhibitory action or cell infiltration inhibitory action; for treating inflammatory diseases and autoimmune diseases such as inflammatory bowel diseases and rheumatoid arthritis |
| 11/24/2005 | US20050261273 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors |
| 11/24/2005 | CA2565211A1 Amino-tetrazoles analogues and methods of use |
| 11/22/2005 | CA2068066C Herpesvirus particles and vaccine |